Sign In
Buy NMTC
$1.69
-0.0100 (-0.588%)
At Close: Jul 31, 2026
NeuroOne Medical Technologies Corporation (NMTC) Q4 2024 Earnings Call Transcript
09:42am, Tuesday, 17'th Dec 2024
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q4 2024 Earnings Conference Call December 17, 2024 9:00 AM ET Company Participants Dave Rosa - Chief Executive Officer Ron McClurg - Chief Fina
Company's Exclusive Distribution Agreement with Zimmer Biomet included $3.0 Million Upfront Payment: Expected to Drive Revenue and Expand Margins Significantly
NeuroOne Medical Technologies: A Small-Cap Electrode Technology Play With Multiple Catalysts Ahead
03:15am, Tuesday, 10'th Dec 2024
NeuroOne is a commercial stage medical device company with FDA-cleared electrodes used in prominent U.S. medical centers for epilepsy diagnosis and treatment. NMTC is partnered with Zimmer Biomet, a $
NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event
09:30am, Wednesday, 13'th Nov 2024
EDEN PRAIRIE, MN / ACCESSWIRE / November 13, 2024 / NeuroOne Medical Technologies Corporation (Nasdaq:NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical ca
NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System
04:01pm, Thursday, 31'st Oct 2024
License Provides Exclusive Commercialization Rights for US Distribution and Certain OUS MarketsAgreement expected to boost NeuroOne sales revenue and profitability
NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference
09:00am, Thursday, 24'th Oct 2024
EDEN PRAIRIE, Minn.
NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference
09:00am, Thursday, 24'th Oct 2024
EDEN PRAIRIE, Minn., Oct. 24, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving
Enhanced Community Development Awarded $65 Million in New Markets Tax Credits
04:15pm, Wednesday, 02'nd Oct 2024
Recognition is the firm's 10th Federal NMTC award, totaling $495 million since 2006 Recognition is the firm's 10th Federal NMTC award, totaling $495 million since 2006
NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland
09:00am, Tuesday, 10'th Sep 2024
Forty-four ablations performed successfully in one patient Patient currently reportedly seizure free with improvements in mood and memory EDEN PRAIRIE, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE) -- NeuroO
NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference
06:23pm, Thursday, 05'th Sep 2024
EDEN PRAIRIE, Minn., Sept. 05, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improvin
NeuroOne Medical Technologies Corporation (NMTC) Q3 2024 Earnings Call Transcript
07:21pm, Wednesday, 14'th Aug 2024
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q3 2024 Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Dave Rosa - Chief Executive Officer Ron McClurg - Chief Financ
NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
04:00pm, Wednesday, 14'th Aug 2024
EDEN PRAIRIE, Minn., Aug. 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving
NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14
11:30am, Monday, 12'th Aug 2024
EDEN PRAIRIE, Minn., Aug. 12, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgica
The 3 Best Neuroscience Biotech Stocks to Buy Now
07:00am, Friday, 19'th Jul 2024
Problems with the central nervous system are the second leading cause of death globally, the World Health Organization determined in 2022. One reason for this situation is that it's extremely difficul
3 Neurotech Stocks Bridging Mind and Machine
10:30am, Thursday, 18'th Jul 2024
If the prospect of controlling computers and robots with brainpower alone excites you, neurotech stocks are right up your alley. Unfortunately, today's top neurotech company — Elon Musk's Neuralink
